UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 445

Sortiert nach

The extra-pancreatic effects of GLP-1 receptor agonists: a focus on the cardiovascular, gastrointestinal and central nervous systems

Diabetes, obesity & metabolism, 2014-08, Vol.16 (8), p.673-688

2014

Volltextzugriff (PDF)

SGLT-2 inhibition with canagliflozin: a new option for the treatment of type 2 diabetes

Deutsche medizinische Wochenschrift (1946), 2014-02, Vol.139 Suppl 2, p.S52

Seufert, J

2014

Volltextzugriff (PDF)

P312 Liraglutide + metformine : bénéfices cliniques associés au switch ou à l’utilisation précoce du liraglutide dans le traitement du diabète de type 2

Diabetes & metabolism, 2014-03, Vol.40, p.A101-A101

2014

Volltextzugriff (PDF)

P1158 Association du liraglutide à la metformine chez les patients diabétiques de type-2 : bénéfices cliniques associés à la substitution ou à l’utilisation précoce du liraglutide dans l’évolution du diabète

Diabetes & metabolism, 2013-03, Vol.39, p.A68-A68

2013

Volltextzugriff (PDF)

Impact of an acceptance facilitating intervention on diabetes patients’ acceptance of Internet-based interventions for depression: A randomized controlled trial

Diabetes research and clinical practice, 2014-07, Vol.105 (1), p.30-39

2014

Volltextzugriff (PDF)

Inkretinforschung und Inkretin-basierte Diabetestherapie

Diabetologe, 2017-11, Vol.13 (7), p.474-474

2017

Volltextzugriff (PDF)

Cardiovascular and Cerebrovascular Comorbidities of Hypokalemic and Normokalemic Primary Aldosteronism: Results of the German Conn’s Registry

The journal of clinical endocrinology and metabolism, 2009-04, Vol.94 (4), p.1125-1130

2009

Volltextzugriff (PDF)

Subnational estimates of vitamin A supplementation coverage in children: a geospatial analysis of 45 low- and middle-income countries

Public health (London), 2024-03, Vol.228, p.194-199

2024

Volltextzugriff (PDF)

Ajout de levemir au liraglutide en association à la metformine améliorant le contrôle glycémique, avec une perte de poids maintenue: données à 52 semaines

Annales d'endocrinologie, 2012-09, Vol.73 (4), p.402-402

2012

Volltextzugriff (PDF)

Efficacy and safety of titrated canagliflozin in patients with type 2 diabetes mellitus inadequately controlled on metformin and sitagliptin

Diabetes, obesity & metabolism, 2016-08, Vol.18 (8), p.812-819

2016

Volltextzugriff (PDF)

Oral add-on therapy to metformin in type 2 diabetes mellitus: a direct comparison beween canagliflozin and glimepiride

Deutsche medizinische Wochenschrift (1946), 2014-02, Vol.139 Suppl 2, p.S65

Seufert, J

2014

Volltextzugriff (PDF)

β-Zell-Ersatz-Therapie

Diabetologe, 2015-11, Vol.11 (7), p.534-537

2015

Volltextzugriff (PDF)

Extreme photometric and polarimetric variability of blazar S4 0954+65 at its maximum optical and γ-ray brightness levels

Monthly notices of the Royal Astronomical Society, 2023-10, Vol.526 (3), p.4502-4513

2023

Volltextzugriff (PDF)

Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis

Diabetologia, 2010-07, Vol.53 (7), p.1258-1269

2010

Volltextzugriff (PDF)

Gender-specific Effects of Treatment with Lifestyle, Metformin or Sulfonylurea on Glycemic Control and Body Weight: A German Multicenter Analysis on 9 108 Patients

Experimental and clinical endocrinology & diabetes, 2015-11, Vol.123 (10), p.622

2015

Volltextzugriff (PDF)

Impact of diabetes duration on achieved reductions in glycated haemoglobin, fasting plasma glucose and body weight with liraglutide treatment for up to 28 weeks: a meta-analysis of seven phase III trials

Diabetes, obesity & metabolism, 2016-07, Vol.18 (7), p.721-724

2016

Volltextzugriff (PDF)

Beta-cell replacement and regeneration: Strategies of cell-based therapy for type 1 diabetes mellitus

Diabetes research and clinical practice, 2008-03, Vol.79 (3), p.389-399

2008

Volltextzugriff (PDF)

Insulin degludec does not increase antibody formation versus insulin glargine: an evaluation of phase IIIa trials

Diabetes, obesity & metabolism, 2016-07, Vol.18 (7), p.716-720

2016

Volltextzugriff (PDF)

Multiple complications and frequent severe hypoglycaemia in 'elderly' and 'old' patients with Type 1 diabetes

Diabetic medicine, 2012-08, Vol.29 (8), p.e176-e179

2012

Volltextzugriff (PDF)

Composite efficacy parameters and predictors of hypoglycaemia in basal-plus insulin therapy-a combined analysis of 713 type 2 diabetic patients

Diabetes, obesity & metabolism, 2014-03, Vol.16 (3), p.248-254

2014

Volltextzugriff (PDF)

Leptin suppression of insulin secretion and gene expression in human pancreatic islets : Implications for the development of adipogenic diabetes mellitus

The journal of clinical endocrinology and metabolism, 1999-02, Vol.84 (2), p.670-676

1999

Volltextzugriff (PDF)

L’augmentation de la fréquence cardiaque sous semaglutide n’a pas entraîné d’augmentation des effets indésirables cardiaques dans l’étude SUSTAIN 6

Annales d'endocrinologie, 2018-09, Vol.79 (4), p.263-263

2018

Volltextzugriff (PDF)

Tumoren der Nebenschilddrüse

Der Onkologe, 2013-06, Vol.19 (6), p.505-512

2013

Volltextzugriff (PDF)

Praxisempfehlungen der Deutschen Diabetes-Gesellschaft in Der Diabetologe

Diabetologie (Online), 2019-01, Vol.15 (1), p.4-5

2019

Volltextzugriff (PDF)

Aktuelle Diagnostik und Therapie von gastroenteropankreatischen neuroendokrinen Tumoren (GEP-NET)

Der Onkologe, 2013-03, Vol.19 (3), p.218-223

2013

Volltextzugriff (PDF)

1 – 25 von 445

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(346)
Mit Volltextzugriff
(368)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(220)
Life Sciences & Biomedicine
(152)
Humans
(125)
Female
(66)
Male
(58)
Physical Sciences
(58)
Biological And Medical Sciences
(51)
Endocrinology & Metabolism
(49)
Adult
(44)
Middle Aged
(43)
Physics
(42)
Animals
(41)
Diabetes
(39)
Aged
(35)
Technology
(33)
Medical Sciences
(32)
Fundamental And Applied Biological Sciences. Psychology
(29)
Diabetes Mellitus
(25)
Diabetes Mellitus, Type 2 - Drug Therapy
(23)
Exact Sciences And Technology
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The extra-pancreatic effects of GLP-1 receptor agonists: a focus on the cardiovascular, gastrointestinal and central nervous systems

SGLT-2 inhibition with canagliflozin: a new option for the treatment of type 2 diabetes

P312 Liraglutide + metformine : bénéfices cliniques associés au switch ou à l’utilisation précoce du liraglutide dans le traitement du diabète de type 2

P1158 Association du liraglutide à la metformine chez les patients diabétiques de type-2 : bénéfices cliniques associés à la substitution ou à l’utilisation précoce du liraglutide dans l’évolution du diabète

Impact of an acceptance facilitating intervention on diabetes patients’ acceptance of Internet-based interventions for depression: A randomized controlled trial

Inkretinforschung und Inkretin-basierte Diabetestherapie

Cardiovascular and Cerebrovascular Comorbidities of Hypokalemic and Normokalemic Primary Aldosteronism: Results of the German Conn’s Registry

Subnational estimates of vitamin A supplementation coverage in children: a geospatial analysis of 45 low- and middle-income countries

Ajout de levemir au liraglutide en association à la metformine améliorant le contrôle glycémique, avec une perte de poids maintenue: données à 52 semaines

Efficacy and safety of titrated canagliflozin in patients with type 2 diabetes mellitus inadequately controlled on metformin and sitagliptin

Oral add-on therapy to metformin in type 2 diabetes mellitus: a direct comparison beween canagliflozin and glimepiride

β-Zell-Ersatz-Therapie

Extreme photometric and polarimetric variability of blazar S4 0954+65 at its maximum optical and γ-ray brightness levels

Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis

Gender-specific Effects of Treatment with Lifestyle, Metformin or Sulfonylurea on Glycemic Control and Body Weight: A German Multicenter Analysis on 9 108 Patients

Impact of diabetes duration on achieved reductions in glycated haemoglobin, fasting plasma glucose and body weight with liraglutide treatment for up to 28 weeks: a meta-analysis of seven phase III trials

Beta-cell replacement and regeneration: Strategies of cell-based therapy for type 1 diabetes mellitus

Insulin degludec does not increase antibody formation versus insulin glargine: an evaluation of phase IIIa trials

Multiple complications and frequent severe hypoglycaemia in 'elderly' and 'old' patients with Type 1 diabetes

Composite efficacy parameters and predictors of hypoglycaemia in basal-plus insulin therapy-a combined analysis of 713 type 2 diabetic patients

Leptin suppression of insulin secretion and gene expression in human pancreatic islets : Implications for the development of adipogenic diabetes mellitus

L’augmentation de la fréquence cardiaque sous semaglutide n’a pas entraîné d’augmentation des effets indésirables cardiaques dans l’étude SUSTAIN 6

Tumoren der Nebenschilddrüse

Praxisempfehlungen der Deutschen Diabetes-Gesellschaft in Der Diabetologe

Aktuelle Diagnostik und Therapie von gastroenteropankreatischen neuroendokrinen Tumoren (GEP-NET)

Suchergebnisse filtern